Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Breast Cancer

Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

202 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

HER2-positive Breast Cancer trial results

Active, Not Recruiting

Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]

NCT03747120

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • New Mexico Cancer Center Albuquerque, New Mexico, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors

NCT05593094

Conditions
Advanced Solid Tumors, Brain Diseases, Brain Neoplasms, +7 more
Locations
  • Arizona Clinical Research Center, Inc.;Hematology Oncology Physicians - Aoa Tucson, Arizona, United States
  • TOI Clinical Research Cerritos, California, United States
  • UCSF Helen Diller Family CCC San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer

NCT06172127

Conditions
Breast Diseases, Breast Neoplasms, HER2-positive Breast Cancer, +4 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Northwell Health New York, United States
  • Institute Paoli Calmettes Marseille, France
  • Hopital Europeen Georges Pompidou Paris, France
View all 36 locations
View Trial Details
Active, Not Recruiting

Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer

NCT05705401

Conditions
HER2-positive Breast Cancer
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 418 locations
View Trial Details

Related conditions